RE: Jamrock4 Aug 2025 14:58
BigC
I feel that the company will have over 3m left when they next give a trading update due to running. Costs based on the same last year as stated in recent results.
The thing for me is moving forward because this deal with Boots could be the catalyst need to move the share price when Boots finally announce the
1, tests
2, How many stores will stock them
3, phlebotomy plans
4, who covers the costs for packing etc.
Knowing the potential revenue definitely helps MHC.
I do believe more deals coming which is why currently Directors can’t buy or exercise 4E in the resolutions because they are party to price sensitive information.
Just my opinion but I do see some major announcements from Boots regarding plans to help NHS ease GP waiting lists utilising both facilities and tests available.
I feel going to see a GP as we do currently could be a thing of the past because Boots facilities could prove cost saving and effective using Boots facilities.
Also the current strikes currently and slowdown by GPs could help government decide to change current system that is clearly broken and outdated.
MHC and Boots and other test providers like ABDX could be big winners in my opinion